Relative risk and attributable risk needed to interpret 'Factors predictive of infection in cyclophosphamide-treated lupus patients': Comment on the article by Pryor et al

G. S. Alarcon; L. E. Kahl

doi:10.1002/art.32

Relative risk and attributable risk needed to interpret 'Factors predictive of infection in cyclophosphamide-treated lupus patients': Comment on the article by Pryor et al

G. S. Alarcon, L. E. Kahl

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	1186
Number of pages	1
Journal	Arthritis and rheumatism
Volume	40
Issue number	6
DOIs	https://doi.org/10.1002/art.32
State	Published - 1997
Externally published	Yes

ASJC Scopus subject areas

Immunology and Allergy
Rheumatology
Immunology
Pharmacology (medical)

Access to Document

10.1002/art.32

Cite this

@article{cbcf842a497f474da559115ff9ac0f18,

title = "Relative risk and attributable risk needed to interpret 'Factors predictive of infection in cyclophosphamide-treated lupus patients': Comment on the article by Pryor et al",

author = "Alarcon, {G. S.} and Kahl, {L. E.}",

year = "1997",

doi = "10.1002/art.32",

language = "English (US)",

volume = "40",

pages = "1186",

journal = "Arthritis and Rheumatology",

issn = "2326-5191",

publisher = "John Wiley and Sons Ltd",

number = "6",

}

TY - JOUR

T1 - Relative risk and attributable risk needed to interpret 'Factors predictive of infection in cyclophosphamide-treated lupus patients'

T2 - Comment on the article by Pryor et al

AU - Alarcon, G. S.

AU - Kahl, L. E.

PY - 1997

Y1 - 1997

UR - http://www.scopus.com/inward/record.url?scp=0030948649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030948649&partnerID=8YFLogxK

U2 - 10.1002/art.32

DO - 10.1002/art.32

M3 - Letter

C2 - 9182938

AN - SCOPUS:0030948649

VL - 40

SP - 1186

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 6

ER -

Relative risk and attributable risk needed to interpret 'Factors predictive of infection in cyclophosphamide-treated lupus patients': Comment on the article by Pryor et al

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this